Published in Blood Weekly, November 3rd, 2005
"Patients with stable vitiligo can be helped surgically using transplantation of autologous cultured melanocytes, but there is a need for a culture methodology that is free from xenobiotic agents and for a simple way of delivering cultured melanocytes to the patient to achieve pigmentation with good wound healing.
"The aim of this study was to develop a chemically defined surface, suitable for the coculture of melanocytes and keratinocytes which could be used in the future for the treatment of vitiligo patients to achieve both restoration of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.